MEDDIC

MEDDIC is a B2B sales qualification framework built on six checkpoints: Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion. A rep works a deal against all six to judge whether it is real and how likely it is to close at the forecasted value. A deal missing three of the six is not a commit, no matter what the close date says.

Sales teams use MEDDIC to qualify opportunities. Revenue teams get more out of it when each element is read as a deal-health signal that feeds the forecast, because a soft qualification score shows up later as a missed number.

The six elements as deal-health signals

Metrics. The quantified economic result the buyer expects. When a deal carries a documented metric, the amount in the CRM is anchored to a business case. When it does not, the amount is a guess, and guessed amounts close low. ORM sees this directly: a pipeline can average $80,000 per deal while closed-won averages $40,000. A missing M is an early warning that the forecasted value is inflated. Economic Buyer. The person who controls the discretionary budget. A deal marked commit where the rep has never spoken to the economic buyer is running on a champion's optimism. Whether the EB has been engaged is a binary health flag worth checking on every late-stage opportunity. Decision Criteria. The formal and informal standards the buyer will judge you against. When criteria are documented early, the deal has a defined shape. When new criteria surface late in the cycle, a competitor is rewriting the scorecard, and the close date is about to move. Decision Process. The real steps from evaluation to signature, including security review and procurement. This element maps straight to the close date. ORM's strongest slippage signal is a rep changing the close date, and deals that slip from one quarter to the next close less often even when they sit in commit. A deal with no mapped decision process has an arbitrary close date, and arbitrary close dates are the ones that slip. Identify Pain. The business pain forcing the buyer to act. Strong pain drives velocity. Weak pain lets a deal age past its expected window. ORM groups opportunities with a machine learning model and predicts a close curve for each group, with most deals closing before week 12. A deal drifting past its curve with no urgent pain is stalling, and the clearest tell is a lack of activity: no change in the record, no reply from the buyer. Champion. The internal advocate who sells for you when you are not in the room. Champion strength shows up as movement. ORM counts a change in stage, close date, or amount as meaningful activity. A silent deal, where the buyer stops returning calls and nothing in the record changes, means the champion has gone quiet or never existed.

Why MEDDIC belongs in the forecast

Pipeline coverage tells you how much pipeline exists. MEDDIC tells you which of it is real. A team can hold 4x coverage and still miss when the deals underneath are thin on Metrics and short a Champion. Scoring every opportunity against the six elements turns a soft commit into an honest one, and it gives the forecast something firmer than a close date to stand on.